Skip to main content

Table 1 Demography, ITT population of first (blinded) phase of the study

From: Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up

 

High dose N = 64

Low dose N = 60 (59a)

Total N = 124 (123a)

Sex (n) male

41

38

79

female

23

22 (21a)

45 (44a)

Age [years] Mean ± SD

3.9 ± 2.8

4.4 ± 2.7

4.1 ± 2.8

Range

0 - 13

0 - 13

0 - 13

Weight [Kg] Mean ± SD

26.3 ± 13.0

24.6 ± 13.9

25.4 ± 13.4

Range

3 - 65

2 - 74

2 - 74

  1. aFor one animal no baseline data were available. It could therefore not be included in the primary efficacy evaluation